Peroxisome Proliferator‐Activated Receptor (PPAR) Agonists for Patients With Primary Biliary Cholangitis With Inadequate Response to Ursodeoxycholic Acid (UDCA): A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

ABSTRACT Objective Peroxisome proliferator‐activated receptor (PPAR) agonists are agents used for patients with primary biliary cholangitis (PBC) who do not respond to conventional agents like ursodeoxycholic acid (UDCA). This meta‐analysis aimed to assess the safety and efficacy of PPAR agonists, i...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Maadeha H. Zaidi, Zaroon Haider, FNU Sadia, Muhammad Tayyab, Muhammad Naveed Tariq, Hasaan H. Ans, Muhammad Bilal Javaid, Ahmad Khan, Muhammad Hassan Ahmad, Rahman Rasheed, Uzair Jafar, Huzaifa Ahmad Cheema, Asma'a Munasar Ali Alsubari, Muhammad Shahzil, Essam Rashad, Rehmat Ullah Awan, Hassam Ali, Prasun K. Jalal
Format:	Artigo
Język:	Inglês
Wydane:	Wiley 2025-06-01
Seria:	JGH Open
Hasła przedmiotowe:	elafibranor fibrates PBC PPAR agonist primary biliary cholangitis saroglitazar
Dostęp online:	https://doi.org/10.1002/jgh3.70196
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!